Esperion Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 80.1M | 168.4M | 87.3M | 82.4M | 65.0M | 69.1M | 51.6M | 73.8M |
| Cost of Goods Sold | 34.6M | 27.9M | 55.4M | 28.5M | 31.5M | 25.6M | 17.3M | 15.6M |
| Gross Profit | 45.5M | 140.6M | 31.9M | 53.8M | 33.5M | 43.5M | 34.3M | 58.2M |
| R&D Expenses | 9.0M | 13.9M | 14.1M | 7.2M | 12.6M | 11.0M | 10.4M | 11.5M |
| Operating Expenses | 52.1M | 55.4M | 41.8M | 46.7M | 55.6M | 47.9M | 50.4M | 55.6M |
| Operating Income | -6.6M | 85.2M | -10.0M | 7.1M | -22.1M | -4.4M | -16.0M | 2.6M |
| Other Income / Gains | -18.6M | -21.6M | -21.4M | -19.8M | -18.4M | -16.9M | -13.5M | -64.5M |
| Net Income | -25.2M | 61.8M | -31.3M | -12.7M | -40.5M | -21.3M | -29.5M | -61.9M |
| EPS (Diluted) | -0.10 | 0.26 | -0.16 | -0.024 | -0.21 | -0.11 | -0.15 | -0.33 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.568 | 0.835 | 0.365 | 0.654 | 0.515 | 0.629 | 0.665 | 0.789 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 11.4M | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 25.5M | 0 | 0 |
| Selling General And Administrative Expenses | 43.1M | 41.4M | 41.8M | 39.5M | 43.0M | 36.9M | 40.0M | 44.2M |
| Other Expenses | 0 | 0 | -14.1M | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 86.7M | 83.2M | 97.3M | 75.3M | 87.1M | 73.5M | 67.7M | 71.3M |
| Interest Income | 0 | 1.1M | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | -19.8M | 22.6M | 22.1M | 20.5M | 19.4M | 16.4M | 15.1M | 13.7M |
| Depreciation And Amortization | 27K | 26K | 26K | 27K | 26K | 27K | 26K | 10K |
| Ebitda | -45.0M | 86.3M | -9.3M | 7.8M | -21.0M | -4.9M | -14.4M | -48.2M |
| Ebitdaratio | -0.561 | 0.513 | -0.106 | 0.095 | -0.323 | -0.07 | -0.279 | -0.653 |
| Operating Income Ratio | -0.082 | 0.506 | -0.114 | 0.086 | -0.34 | -0.064 | -0.31 | 0.035 |
| Income Before Tax | -25.2M | 63.7M | -31.3M | -12.7M | -40.5M | -21.3M | -29.5M | -61.9M |
| Income Before Tax Ratio | -0.315 | 0.378 | -0.359 | -0.154 | -0.622 | -0.308 | -0.572 | -0.839 |
| Income Tax Expense | 0 | 1.8M | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -0.315 | 0.367 | -0.359 | -0.154 | -0.622 | -0.308 | -0.572 | -0.839 |
| Epsdiluted | -0.10 | 0.22 | -0.16 | -0.024 | -0.21 | -0.11 | -0.15 | -0.33 |
| Weighted Average Shs Out | 251.4M | 236.7M | 198.2M | 196.8M | 196.1M | 195.6M | 194.9M | 188.8M |
| Weighted Average Shs Out Dil | 251.4M | 284.6M | 198.2M | 196.8M | 196.1M | 195.6M | 194.9M | 188.8M |